Baysient

Baysient is a private digital health company that develops cloud-based precision-dosing and therapeutic drug monitoring software for biologics and other difficult-to-manage drugs. Its products use Bayesian pharmacokinetic modeling, routine laboratory data, and patient demographic information to help clinicians individualize dose regimens to target trough concentrations. The company is best known for iDose, which is positioned for anti-inflammatory monoclonal antibodies used in diseases such as inflammatory bowel disease, and it has also expanded into oncology biologic dose optimization with TuMinimize. Baysient presents itself as a model-informed dosing company rather than a traditional drug developer, with commercial software tools used by providers, health systems, and payers. The company also highlights prospective clinical data supporting improved outcomes and reduced anti-drug antibodies with its precision-dosing approach.